NYT – If AbbVie no longer wants to buy Shire, perhaps Allergan does.
That is the proposal being pushed by Paulson & Company, the hedge fund that has stakes in two of those big drug makers, according to people briefed on the matter.
Paulson’s Hedge Fund Urges Botox-Maker Allergan to Consider Buying Shire
This entry was posted in Syndicated. Bookmark the permalink.
